Stockscreener 앱 받기
6.18
4.18%
-0.2699
시간 외 거래:
6.18
전일 마감가:
$6.4499
열려 있는:
$6.4
하루 거래량:
8,847
Relative Volume:
5.04
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+5.64%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$6.00
$6.40
1주일 범위
$5.85
$6.70
52주 변동 폭
$5.85
$6.72
Bioharvest Sciences Inc Stock (BHST) Company Profile
BHST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| BHST | 6.18 | 0 | 0 | 0 | 0 | 0.00 |
| VRTX | 450.37 | 115.10B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.07B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.20B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 25.09B | 3.30B | -501.07M | 1.03B | 11.54 |
Bioharvest Sciences Inc 주식(BHST)의 최신 뉴스
BioHarvest Sciences Engages Investors at Upcoming Conference - TipRanks
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024 - Newsfile
BioHarvest Sciences to Present Growth Strategy at Noble Capital Markets Conference | BHST Stock News - StockTitan
CNVCF (BioHarvest Sciences) GF Value Rank : 2 (As of Nov. 21, 2024) - GuruFocus.com
Ilan Sobel, CEO of BioHarvest Sciences - iHeart
BioHarvest Sciences to Announce Q3 2024 Results - TipRanks
BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time - The Kingston Whig-Standard
BioHarvest Sciences Sets Q3 2024 Earnings Call for November 25 | BHST Stock News - StockTitan
Revenues Tell The Story For BioHarvest Sciences Inc. (CSE:BHSC) As Its Stock Soars 26% - Simply Wall St
BioHarvest shares rise in Nasdaq debut - Proactive Investors USA
BioHarvest Sciences Begins Nasdaq Trading - TipRanks
BioHarvest Sciences Begins Trading on the Nasdaq Global Market - Newsfile
BioHarvest Sciences (BHST) Debuts on Nasdaq Global Market, Sets Q3 Earnings Date | BHST Stock News - StockTitan
BioHarvest Sciences Uplists to Nasdaq, Expanding Shareholder Base - TipRanks
Canada Market’s top losers: Enterprise Group-14.16%, BioHarvest Sciences -12.34% - Business Upturn
BioHarvest Sciences shares to list on Nasdaq next week - Proactive Investors Australia
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market - StockTitan
BioHarvest Sciences set to begin trading on Nasdaq, marking major milestone in U.S. market expansion - Proactive Investors USA
BioHarvest Sciences appoints new CFO - Proactive Investors UK
BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results - Yahoo Finance
BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024 - Yahoo Finance
BioHarvest Sciences reshuffles board amid Nasdaq listing efforts - Proactive Investors USA
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024 - Newsfile
BioHarvest Sciences to Showcase at Global Investment Conference - TipRanks
BioHarvest Sciences Second Quarter 2024 Earnings: US$0.042 loss per share (vs US$0.21 loss in 2Q 2023) - Simply Wall St
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables - Newsfile
BioHarvest Sciences hits sales milestone for VINIA Superfood Coffee - Proactive Investors USA
BioHarvest Sciences closes first tranche of private placement - Proactive Investors UK
BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes - Yahoo Finance
BioHarvest Sciences Announces Record $2 Million Monthly Sales - Yahoo Finance
BioHarvest Sciences Reports First Quarter 2024 Financial Results - StreetInsider.com
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit - BioSpace
BioHarvest Sciences launches contract development and manufacturing organization business unit - Proactive Investors UK
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference By Investing.com - Investing.com Canada
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update - Financial Content
BioHarvest Sciences Inc. Closes Final Tranche of Oversubscribed $13.5M Private Placement - StockTitan
BioHarvest Sciences Announces Major Product Launch of VINIA-Based Functional Coffees - Nasdaq
BioHarvest Sciences Reports Q3 2023 Revenue Demonstrating Continued Growth Momentum - StockTitan
BioHarvest Sciences congratulates ‘Team VINIA’ NFL prospects on draft success - Proactive Investors UK
BioHarvest Introduces its 1st Cannabis Breakthrough Composition with Major Medical and Commercial Implications - BioSpace
CSE Bulletin: INDEXCSE 25 Index Quarterly Rebalancing - Investing News Network
BioHarvest Sciences Hires Dr. Brian S. Cornblatt as Chief Medical Officer - Investing News Network
BioHarvest Sciences Unveils Profile of Unique Cannabis Composition - Investing News Network
BioHarvest Sciences Inc. Quarterly Shareholder Update Live Event April 7, 2022, at 2:00 PM E.T. - Investing News Network
Bioharvest Sciences Inc. Reports Strong Q1 2022 Results on All of the Company's Activities - Investing News Network
Bioharvest Sciences Inc. Successfully Completes Cannabis R&D Program - Investing News Network
BioHarvest Sciences says it has produced cannabis biomass in large-scale industrial bioreactors - Proactive Investors UK
BioHarvest CEO Ilan Sobel: Disrupting Industries with Unique Products and Therapeutic Solutions - Investing News Network
BioHarvest Sciences Inc. Trademarks Its Breakthrough Non-GMO Proven Platform Technology: "BIO-PLANT CELLicitation" - Investing News Network
BioHarvest Sciences Inc. Engages Thunder11 as a Public Relations Agency of Record - Investing News Network
BioHarvest Sciences Inc. to Present at BIO CEO & Investor Conference in New York City on February 14-17, 2022 - Investing News Network
Bioharvest Sciences Inc (BHST) 재무 분석
Bioharvest Sciences Inc (BHST)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.93%
3.55%
자본화:
|
볼륨(24시간):